Sensyne Health welcomes EY report Realising the Value of Healthcare Data which highlights the potential of patient data to be used for healthcare innovation and economic benefit to the UK
Read more
Sensyne Health welcomes EY’s announcement on AI and blockchain to link healthcare reimbursement and actual patient outcomes
Read more
Sensyne Health, Evotec, OSI and the University of Oxford create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
Read more
Bayer joins Sensyne Health consortium working on national linked patient data capability for accelerating the discovery of new medicines
Read more
Sensyne Health Maiden Interim Results 2018
Read more
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and clinical AI for the patient-centred management and treatment of chronic disease
Read more
Sensyne Health and George Eliot Hospital NHS Trust sign Strategic Research Agreement
Read more
Sensyne Health and Wye Valley NHS Trust sign Strategic Research Agreement
Read more
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States
Read more
Sensyne Health welcomes UK government announcement today endorsing the potential of analysing anonymised NHS patient data in an ethical way to improve patient care and accelerate medical research
Read more
Sensyne Health signs Strategic Advisory Services agreement with EY
Read more
Official product launch of GDm-Health™
Read more
Board Appointment: Professor Lionel Tarassenko Appointed as Non-Executive Director and Director of R&D
Read more
Sensyne Health licenses Privitar’s data privacy software
Read more
Sensyne Health welcomes and commits to new government code of conduct for data-driven health and care technologies
Read more
Sensyne Health plc Admission to trading on AIM and First Day of Dealings
Read more
Sensyne Health plc Placing and Proposed Admission to trading on AIM
Read more
Sensyne Health acquires digital health software product for the treatment of heart failure developed by The George Institute for Global Health at the University of Oxford and Oxford University Hospitals NHS Foundation Trust
Read more
Sensyne Health signs Strategic Research Agreement with Oxford University Hospitals NHS Foundation Trust
Read more
Sensyne Health and Chelsea and Westminster Hospital NHS Foundation Trust sign Strategic Research Agreement
Read more
Sensyne Health signs Strategic Research Agreement with South Warwickshire NHS Foundation Trust
Read more
Drayson Health signs Memorandum of Understanding with South Warwickshire NHS Foundation Trust
Read more
Drayson Health welcomes Prime Minister’s comments on the promise of AI
Read more
Professor David Clifton joins Drayson Health as Research Director
Read more
Positive Clinical Trial of GDm-Health™
Read more
CleanSpace recognised in UK Government CMO’s report
Read more
Digital Health Partnership Wins Collaboration Award
Read more
Chelsea and Westminster Hospital partner with Drayson Health
Read more
GDm-Health Published on NHS Digital Tools Library
Read more
Drayson Technologies Agrees Digital Health Deal
Read more

Oxford Office

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

Schrödinger Building,
Heatley Road, Oxford Science Park,
Oxford, OX4 4GE

+44 (0) 330 058 1845

Contact us

For press enquiries, please contact press@sensynehealth.com